文献速递儿童呼吸儿童血液肿瘤与免疫儿童感染

儿童皮肌炎快速进展型间质性肺病的成功治疗

Successful Treatment of Rapidly Progressive Interstitial Lung Disease in Juvenile Dermatomyositis.
PubMed 文献 · Pediatrics · 2024-01-01

本文报告一例4岁低体重女童,以呼吸道症状起病,缺乏典型皮肌炎皮疹,仅有耳轮小丘疹,因近期旅行史诊断延迟,后出现肺出血,抗MDA5抗体高阳性,接受血浆置换、全身激素、JAK抑制剂、B细胞清除剂及静脉免疫球蛋白联合治疗后好转并出院。

要点

  • 抗MDA5阳性儿童皮肌炎可表现为低肌病性、缺乏典型皮疹,易误诊。
  • 快速进展型间质性肺病可并发肺出血,需警惕并早期识别。
  • 联合血浆置换、激素、JAK抑制剂、B细胞清除剂及IVIG可能改善预后。

核心结论

  • 抗MDA5阳性儿童皮肌炎相关快速进展型间质性肺病虽罕见但致命,早期识别并积极联合治疗可改善预后。

研究设计与样本

  • 单例病例报告,描述一例4岁低体重女童的临床表现、诊断过程及治疗转归。

主要发现

  • 患儿以呼吸窘迫起病,快速进展为严重低氧和高碳酸性呼吸衰竭需插管,伴疲劳、间歇发热和转氨酶升高。
  • 因近期旅行史及缺乏典型皮肌炎皮疹(仅耳轮小丘疹)诊断延迟,后因肺出血和耳部病变行风湿病学检查。
  • 肌炎特异性抗体 panel 显示抗MDA5抗体高阳性,接受血浆置换、全身激素、JAK抑制剂、B细胞清除剂及静脉免疫球蛋白联合治疗。
  • 患儿对治疗反应良好,最终拔管出院。

关键数值与推荐

  • 抗MDA5抗体高阳性提示快速进展型间质性肺病高风险,需积极联合免疫治疗。

临床怎么用

  • 对不明原因呼吸衰竭伴转氨酶升高、低肌病表现的患儿,应警惕抗MDA5阳性儿童皮肌炎,即使缺乏典型皮疹也应尽早检测肌炎特异性抗体。
  • 确诊后应尽快启动包括血浆置换、全身激素、JAK抑制剂、B细胞清除剂及静脉免疫球蛋白的联合治疗。

局限性

  • 单例病例报告,结论不能推广至所有抗MDA5阳性儿童皮肌炎患者。
  • 缺乏长期随访数据及对照比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Juvenile dermatomyositis (JDM) is a rare systemic autoimmune disease characterized by cutaneous findings, muscle inflammation, and vasculopathy. Patients with antimelanoma differentiation associated gene 5 (anti-MDA5) JDM may have subtle muscle weakness, absence of pathognomonic rashes, and more polyarthritis and ulcerative skin lesions when compared with other JDM subtypes. Although there is a known association of rapidly progressive interstitial lung disease (RP-ILD) in patients with anti-MDA5 dermatomyositis, few case reports describe this association in the pediatric literature. Even fewer reports describe successful treatment. We report an unusual case of RP-ILD in a pediatric patient with a hypomyopathic presentation complicated by prolonged intubation and pulmonary hemorrhage. A 4-year-old underweight female presented in respiratory distress and quickly progressed to severe hypoxic and hypercarbic respiratory failure requiring intubation. She experienced fatigue, intermittent fever, and transaminitis. The diagnosis was delayed because of recent travel history and a lack of typical cutaneous features of JDM, except a small erythematous papule on her antihelix. Her pulmonary hemorrhage and ear lesion prompted additional rheumatic workup. The myositis-specific antibody panel revealed high positive anti-MDA5 antibodies that prompted aggressive combination therapy with plasmapheresis, systemic steroids, inhibitors of Janus kinase, agents to deplete B-cells, and intravenous immunoglobulin. The patient responded well to treatment and was ultimately extubated and discharged. To our knowledge, this is the first thoroughly documented case of anti-MDA5 JDM with RP-ILD presenting with pulmonary hemorrhage and lacking typical cutaneous features. Early recognition of this highly fatal condition is important for improved prognosis.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Ciaglia K, Ghawji M, Caraballo M, et al. Successful Treatment of Rapidly Progressive Interstitial Lung Disease in Juvenile Dermatomyositis. Pediatrics. 2024. PMID: 38361479. doi:10.1542/peds.2023-063268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。